ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,222.68
0.16%
US Tech 100
17,676.00
0.20%
다우존스 지수
39,512.84
0.32%
Bitcoin
60,587.01
-3.90%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Portage Biotech Inc (PRTG)

  7. Portage Biotech Inc (PRTG) 뉴스

PRTG

Portage Biotech (PRTG)

Portage Biotech Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:PRTG
일자시간출처헤드라인심볼기업
2024/04/1221:01GlobeNewswire Inc.Portage Biotech Announces Plans to Expand its Evaluation of Strategic AlternativesNASDAQ:PRTGPortage Biotech Inc
2024/03/2621:01GlobeNewswire Inc.Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) sharesNASDAQ:PRTGPortage Biotech Inc
2024/03/0907:30Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PRTGPortage Biotech Inc
2024/03/0907:04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTGPortage Biotech Inc
2024/02/2907:19Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PRTGPortage Biotech Inc
2024/02/2907:10GlobeNewswire Inc.Portage Biotech Reports Results for Fiscal Quarter Ended December 31, 2023, and Business UpdateNASDAQ:PRTGPortage Biotech Inc
2024/02/1505:50Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PRTGPortage Biotech Inc
2024/01/1907:09Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTGPortage Biotech Inc
2024/01/0422:10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTGPortage Biotech Inc
2024/01/0422:00GlobeNewswire Inc.Portage Biotech Reports Business and Strategic UpdateNASDAQ:PRTGPortage Biotech Inc
2023/12/0206:05Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PRTGPortage Biotech Inc
2023/11/2906:03Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PRTGPortage Biotech Inc
2023/11/2906:02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTGPortage Biotech Inc
2023/11/2906:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTGPortage Biotech Inc
2023/11/1420:00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PRTGPortage Biotech Inc
2023/11/1320:10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTGPortage Biotech Inc
2023/11/0814:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PRTGPortage Biotech Inc
2023/11/0806:50Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PRTGPortage Biotech Inc
2023/11/0622:01GlobeNewswire Inc.Portage Biotech Presents Updates on its iNKT and Adenosine programs at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual MeetingNASDAQ:PRTGPortage Biotech Inc
2023/11/0105:05Edgar (US Regulatory)Form F-1 - Registration statement for certain foreign private issuersNASDAQ:PRTGPortage Biotech Inc
2023/09/2921:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTGPortage Biotech Inc
2023/09/0905:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTGPortage Biotech Inc
2023/08/3021:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTGPortage Biotech Inc
2023/08/3005:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTGPortage Biotech Inc
2023/08/1505:52Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTGPortage Biotech Inc
2023/08/0106:12Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:PRTGPortage Biotech Inc
2023/06/2119:04Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRTGPortage Biotech Inc
2023/05/0121:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRTGPortage Biotech Inc
2023/03/1419:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRTGPortage Biotech Inc
2023/01/0706:50Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRTGPortage Biotech Inc
 검색 관련기사 보기:NASDAQ:PRTG

최근 히스토리

NYSE
VZ
Verizon Communications
FX
USDEUR
US Dollar vs Euro
NASDAQ
AMZN
Amazon.com
NYSE
MCD
McDonalds
USOTC
BASFY
BASF (QX)
USI
USTECH100
US Tech 100
NYSE
CVX
Chevron
FX
USDJPY
US Dollar vs Yen
AMEX
SPY
SPDR S&P 500
USOTC
RHHBY
Roche (QX)
NASDAQ
NVDA
NVIDIA
NASDAQ
TSLA
Tesla
COIN
SOLUSD
Solana
CCOM
SILVER
SILVER
USOTC
BNPQY
BNP Paribas (QX)
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유